Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with University of Georgia - Galectin Therapeutics (NASDAQ:GALT)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeuticsthat target galectin proteins to treat fibrosis and cancer, announced todaythe establishment of a collaborative drug discovery program with Dr. Geert-JanBoons' laboratory located in the Complex Carbohydrate Research Center at theUniversity of Georgia. This program is focused on the discovery of newcarbohydrate molecules that can be used in the therapy of diseases wheregalectin proteins play a major role, including cancer and inflammatory andfibrotic disorders.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!